Noncompaction cardiomyopathy medical therapy
|
Noncompaction Cardiomyopathy Microchapters |
|
Pathophysiology |
|---|
|
Differentiating Noncompaction Cardiomyopathy from other Diseases |
|
Diagnosis |
|
Treatment |
|
Noncompaction cardiomyopathy medical therapy On the Web |
|
Risk calculators and risk factors for Noncompaction cardiomyopathy medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Overview
The management of NCC is similar to that of other cardiomyopathies and includes the use of ACE inhibitors, beta blockers and aspirin.
Antiplatelet Therapy
Given the risk of embolization, these patients are generally treated with prophylactic aspirin.
Beta Blockade
NCC is assocatiated with an increased risk of arrhythmias including ventricular tachyarrhythmias. Beta blockade may reduce this risk.
Automatic Implantable Cardiac Defibrillator (AICD)
Implantation of an automatic internal cardiac defibrillator AICD may be appropriate in patients who are deemed to be at increased risk of sudden cardiac death. A small study from the Netherlands identified young females with premature ventricular contractions (PVCs) at risk of sudden death[1].